People
Kallyope Chief Executive Officer Nancy Thornberry said the company’s journey to becoming a “first-mover in the gut-brain axis space” is coming to fruition.
Rocket Pharmaceuticals CEO Gaurav Shah said the remote-working policies that have resulted from the global COVID-19 pandemic have created a challenging time for the pharmaceutical industry, as well as the rest of the global community, but believes a silver lining will be forthcoming.
To combat the growing number of cases, the state is pulling out the stops in testing the use of antibodies from the plasma of recovered COVID-19 patients.
“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”
Organizations should plan for the worst and hope for the best, ensuring critical research can be continued without risking the safety of employees or the continuity of the company.
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
Europe’s new pharmaceutical roadmap is designed to reinvigorate innovation in the pharmaceutical industry to make it competitive with the United States.
Insys founder John Kapoor is using the coronavirus pandemic as part of his legal defense to remain out of prison while he appeals his January racketeering conviction.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
“We are delighted to have these premier life science investors supporting our Series B financing,” said David J. Earp, Circle’s President and CEO.
PRESS RELEASES